DigiPrEP: A Gilead Sciences-funded study to test the use of a digital enabled PrEP (DigiPrEP) to measure PrEP adherence in men who have sex with men (MSM) who use substances other than alcohol.
Consists of individual qualitative interviews to understand how MSM would use and respond to digital pills that measure real-time medication ingestion (Aim 1) and a 90-day feasibility and acceptability trial in which MSM would use the digital pill as a tool to help with PrEP adherence.
Interested? Contact us at 617.927.6266 or digiprep@fenwayhealth.org